カツラ ヒデキ
Katsura Hideki
桂 秀樹 所属 医学部 医学科(東京女子医科大学病院) 職種 客員教授 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | Nationwide survey in Japan of the causative diseases of bloody sputum and hemoptysis in departments of respiratory medicine at university hospitals and core hospitals. |
掲載誌名 | 正式名:Respiratory investigation 略 称:Respir Investig ISSNコード:22125353/22125345 |
掲載区分 | 国外 |
巻・号・頁 | 62(3),pp.395-401 |
著者・共著者 | Fujii Hiroaki†, Hara Yu, Obase Yasushi, Haranaga Shusaku, Takahashi Hidenori, Shinkai Masaharu, Terada Jiro, Ikari Jun, Katsura Hideki, Yamamoto Kazuko, Suzuki Takuji, Tagaya Etsuko, Mukae Hiroshi, Kaneko Takeshi |
発行年月 | 2024/05 |
概要 | BACKGROUND:The Guidelines for the Management of Cough and Sputum (2019) of the Japanese Respiratory Society (JRS) were the first internationally published guidelines for the management of sputum. However, the data used to determine the causative diseases of bloody sputum and hemoptysis in these guidelines were not obtained in Japan.METHODS:A retrospective analysis was performed using the clinical information of patients with bloody sputum or hemoptysis who visited the department of respiratory medicine at a university or core hospital in Japan.RESULTS:Included in the study were 556 patients (median age, 73 years; age range, 21-98 years; 302 males (54.3%)). The main causative diseases were bronchiectasis (102 patients (18.3%)), lung cancer (97 patients (17.4%)), and non-tuberculous mycobacterial disease (89 patients (16%)). Sex and age differences were observed in the frequency of causative diseases of bloody sputum and hemoptysis. The most common cause was lung cancer in males (26%), bronchiectasis in females (29%), lung cancer in patients aged <65 years (19%), and bronchiectasis in those aged >65 years (20%).CONCLUSIONS:The present study is the first to investigate the causative diseases of bloody sputum and hemoptysis using data obtained in Japan. When investigating the causative diseases of bloody sputum and hemoptysis, it is important to take the sex and age of the patients into account. |
DOI | 10.1016/j.resinv.2024.02.003 |
PMID | 38484503 |